AKT1 and breast cancer: Naringenin downregulated the PI3K/AKT pathway-increased naringenin-induced apoptosis and the sensitivity of BC cells to DNA-damaging drugs (camptothecin, 5-fluorouracil, doxorubicin, cisplatin, ellipticine, and etoposide) [160].